Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone

Sheng-Wen Niu1,2,3,4, Chi-Chih Hung3,4, Hugo Y-H Lin2,3,4

  • 1Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, No. 100, Tzyou 1st Road, Kaohsiung 807, Taiwan.

Insights

Benzbromarone, a uricosuric agent, significantly reduces stroke incidence in gout patients. This study found fewer strokes in benzbromarone users compared to non-users, highlighting its potential protective effect against stroke in this population.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Gout is a significant risk factor for atherosclerotic events, including stroke and myocardial infarction.
  • Stroke prevalence is notably higher in individuals diagnosed with gout.
  • Uricosuric agents are used to manage gout by lowering uric acid levels.

Purpose of the Study:

  • To investigate the impact of benzbromarone, a uricosuric agent, on the incidence of stroke.
  • To evaluate the efficacy of benzbromarone in mitigating stroke risk within the gout patient population.

Main Methods:

  • Utilized data from the Taiwanese National Health Insurance Registration Database (NHIRD).
  • Established a benzbromarone user cohort of 15,143 patients, matched with non-users from the gout population.
  • Employed Cox proportional hazard regression analysis to assess stroke incidence.

Main Results:

  • Benzbromarone users exhibited a significantly lower incidence of stroke compared to non-users.
  • Hazard ratios for stroke were reduced in male benzbromarone users.
  • Significant reductions in stroke incidence were observed in benzbromarone users aged 40-59 and ≥60 years.

Conclusions:

  • Benzbromarone use is associated with a decreased incidence of stroke in patients with gout.
  • The uricosuric agent benzbromarone demonstrates a protective effect against stroke in the gout population.
  • Findings suggest benzbromarone may be a valuable therapeutic option for stroke prevention in gout patients.

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
939
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
59
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
989
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
44
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
744
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
46